Eagle Pharmaceuticals Current Assets

Eagle Pharmaceuticals (EGRX) currently reports a current assets of $190M as of June 2023. That compares with $190M in the prior-year period — down 3.7% year over year. Use the charts on this page to explore Eagle Pharmaceuticals's current assets history and peer comparisons.

Eagle Pharmaceuticals's current assets decreased from $190M to $190M — a 3.7% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eagle Pharmaceuticals reported $190M in current assets as of June 2023. That compares with $190M in the prior-year period — down 3.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $190M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eagle Pharmaceuticals, and consider following EGRX for alerts when major investors trade the stock.

Eagle Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $190M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EGRX with unrelated industries.